Invention Grant
- Patent Title: Substituted imidazoles as casein kinase 1 D/E inhibitors
- Patent Title (中): 取代的咪唑作为酪蛋白激酶1D / E抑制剂
-
Application No.: US14653895Application Date: 2013-12-20
-
Publication No.: US09556179B2Publication Date: 2017-01-31
- Inventor: Upender Velaparthi , Chetan Padmakar Darne , Dharmpal S. Dodd , Anthony J. Sampognaro , Mark D. Wittman , Selvakumar Kumaravel , Dibakar Mullick , Peiying Liu , Chandrasekhar Reddy Rachamreddy
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu; Elliott Korsen
- International Application: PCT/US2013/076795 WO 20131220
- International Announcement: WO2014/100533 WO 20140626
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US20150344481A1 NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS Public/Granted day:2015-12-03
Information query
